Behavioral and Social Research Funding Opportunities and Applicant Resources

Time-Limited Funding Opportunities
BSR Opportunities in AD/ADRD
Current Funding Opportunities
Research and Funding FAQs

Time-Limited Funding Opportunities

Time-limited FOAs typically have a single due date and a special allocation of funds. BSR is accepting grant applications to a number of time-limited funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current time-limited funding opportunities.

FOA Number	Title	Focus	Release Date	Final Due Date
PAR-21-207	Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimer’s Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) NIA intends to commit $2,250,000 in both FY 2022 and FY 2023 to fund 4 to 6 awards. Applicant resources for PAR-21-2017	AD/ADRD	4/6/2021	1/26/2022
RFA-DA-22-036	NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) The NIH HEAL Initiative intends to commit $2,700,000 in FY 2022 to fund up to 4 awards.	Aging	11/16/2021	3/2/2022
RFA-AG-23-004	Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed) NIA intends to commit $3,300,000 in FY 2023 to fund up to 5 awards.	AD/ADRD Aging	11/16/2021	3/3/2022
RFA-AG-23-001	Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) NIA intends to commit $6,000,000 in FY 2023 to fund 6-10 awards.	AD/ADRD Aging	10/26/2021	3/3/2022
RFA-AG-23-003	Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) NIA intends to commit $1,600,000 in FY 2023 to fund 1 award. Frequently Asked Questions for RFA-AG-23-003	Aging	12/20/2021	7/1/2022
RFA-MH-22-135	Social Disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) NIA intends to commit a total of $2,000,000 in FY 2023 to fund 4-6 awards for this FOA and the companion FOA, RFA-MH-22-136.	AD/ADRD	12/23/2021	10/15/2022
RFA-MH-22-136	Social Disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) NIA intends to commit a total of $2,000,000 in FY 2023 to fund 4-6 awards for this FOA and the companion FOA, RFA-MH-22-136.	AD/ADRD	12/23/2021	10/15/2022

BSR Opportunities in AD/ADRD

Parent Funding Opportunities and Associated NOSIs

NIA has two parent funding opportunities that invite applications on a variety of Alzheimer’s disease and Alzheimer's disease related dementias research topics. PAR-22-093 is for R01 applications and PAR-22-094 is for R21 applications. Notices of Special Interest associated with these parent FOAs specify high priority behavioral and social research topics and are listed below.

FOA Number	Title	Release Date	Expiration Date
NOT-AG-21-051	Notice of Special Interest (NOSI): Sleep Disorders and Circadian Clock Disruption in Alzheimer's Disease and other Dementias of Aging	1/11/2022	11/13/2024
NOT-AG-21-050	Notice of Special Interest (NOSI): Sex and Gender Differences in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)	1/6/2022	11/13/2024
NOT-AG-21-049	Notice of Special Interest (NOSI): Dementia Care Workforce for Those Living with Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)	1/6/2022	11/13/2024
NOT-AG-21-048	Notice of Special Interest (NOSI): Digital Technology for Early Detection and Monitoring of Alzheimer’s Disease and Related Dementias	1/6/2022	11/13/2024
NOT-AG-21-047	Notice of Special Interest (NOSI): Behavioral and Social Science Priority Areas in Dementia Care Partner/Caregiver Research	1/6/2022	11/13/2024
NOT-AG-21-046	Notice of Special Interest (NOSI): Dementia Care Research: Programs and services for persons with dementia	1/6/2022	11/13/2024
NOT-AG-21-045	Notice of Special Interest (NOSI): Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience	1/6/2022	11/13/2024
NOT-AG-21-044	Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimer's Disease	1/6/2022	11/13/2024
NOT-AG-21-039	Notice of Special Interest: Understanding Alzheimer's Disease in the Context of the Aging Brain	12/30/2021	11/13/2024
NOT-AG-21-036	Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer's Disease and Related Dementias	1/7/2022	11/13/2024
NOT-AG-21-035	Notice of Special Interest: Collaborative Studies on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)	12/30/2021	11/13/2024
NOT-AG-21-033	Notice of Special Interest: Health Disparities and Alzheimer's Disease	12/22/2021	11/13/2024

Major Opportunities in AD/ADRD Research

In addition to the parent AD/ADRD funding opportunities, BSR participates in other announcements aimed specifically at building AD/ADRD research infrastructure, developing clinical trials, and more. AD/ADRD research is also included in many other announcements in which BSR participates, detailed in the Current Funding Opportunities section below.

FOA Number	Title	Release Date	Expiration Date
PAR-21-360	Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)	1/10/2022	1/8/2025
PAR-21-359	Early and Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)	1/10/2022	1/8/2025
PAR-22-362	NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)	1/7/2022	10/2/2024
PAR-22-077	NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)	12/22/2022	10/18/2024
PAR-21-307	Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)	8/11/2021	2/14/2022
PAR-21-308	Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required)	8/11/2021	2/14/2022
PAR-21-141	AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)	3/4/2021	9/8/2023
PAS-19-391	Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed)	10/17/2019	11/17/2022
PAS-19-392	Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed)	10/17/2019	11/17/2022
PAS-19-393	Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed)	10/17/2019	11/17/2022

Current Funding Opportunities

BSR is accepting grant applications to a number of funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current funding opportunities.

The full list of NIA-wide active funding opportunities and NIA-wide AD/ADRD funding opportunities can also be found online.

FOA Number	Title	Focus	Release Date	Expiration Date
NOT-AG-22-005	Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pain, Pain Management, and Opioids in Aging	AD/ADRD Aging	12/22/2021	4/29/2022
NOT-AG-22-004	Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging	AD/ADRD Aging	12/22/2021	01/8/2025
PAR-21-352	Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trial Required)	AD/ADRD Aging	10/5/2021	9/8/2024
PAR-21-350	Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)	AD/ADRD Aging	10/5/2021	6/22/2024
PAR-21-349	Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)	AD/ADRD Aging	10/5/2021	6/22/2014
NOT-AG-21-020	Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research	AD/ADRD Aging	8/23/2021	9/8/2023
NOT-MH-21-330	Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations	COVID-19	8/20/2021	9/8/2024
PAR-21-281	Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)	AD/ADRD Aging	7/9/2021	5/8/2023
PAR-21-280	Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)	AD/ADRD Aging	7/9/2021	5/8/2023
PAR-21-275	The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)	AD/ADRD Aging	6/25/2021	9/8/2024
NOT-OD-21-100	Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health	AD/ADRD Aging	4/8/2021	6/8/2024
NOT-AT-21-002	Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease	AD/ADRD Aging	1/22/2021	5/7/2024
PAR-21-099	Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional)	AD/ADRD Aging	12/23/2020	2/17/2023
PAR-21-100	Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)	AD/ADRD Aging	12/23/2020	2/06/2023
NOT-OD-21-011	Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science	AD/ADRD Aging	11/24/2020	11/10/2022
PAR-21-080	Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)	AD/ADRD Aging	11/17/2020	1/8/2023
NOT-AG-21-012	Notice of Special Interest: Integrative Studies of Neural Mechanisms Underlying Fundamental Affective Processes in Aging	AD/ADRD Aging	10/15/2020	1/8/2024
NOT-AG-20-040	Notice of Special Interest: Basic and Translational Research on Affective, Motivational, and Social Function in Normative Aging and/or Alzheimer’s Disease and Related Dementias (AD/ADRD)	AD/ADRD Aging	8/3/2020	1/8/2022
NOT-AG-20-039	Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD)	AD/ADRD Aging	7/21/2020	1/8/2022
PAR-20-266	Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)	AD/ADRD Aging	7/15/2020	6/20/2023
NOT-OD-20-106	Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions	AD/ADRD Aging	5/19/2020	9/26/2022
PA-20-172	Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)	AD/ADRD Aging	4/20/2020	9/8/2023
PAR-20-164	Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)	AD/ADRD Aging	4/3/2022	7/15/2022
NOT-OD-20-079	Notice of Special Interest (NOSI): Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice	AD/ADRD Aging	3/24/2020	1/8/2022
PAR-20-139	Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)	AD/ADRD Aging	3/13/2020	1/14/2023
RFA-NS-20-008	HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)	Aging	10/4/2019	9/9/2022
RFA-NS-20-009	HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)	Aging	10/4/2019	9/9/2022
RFA-NS-20-010	HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)	Aging	10/4/2019	9/9/2022
RFA-NS-20-011	HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)	Aging	10/4/2019	9/9/2022
PAR-19-302	NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)	AD/ADRD Aging	6/24/2019	9/8/2022
PAR-19-274	Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)	AD/ADRD Aging	5/8/2019	5/8/2022
PAR-19-275	Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)	AD/ADRD Aging	5/8/2019	5/8/2022
PAR-19-276	Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)	AD/ADRD Aging	5/8/2019	5/8/2022
PA-19-200	Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)	Aging	2/28/2019	5/8/2022
PA-19-201	Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)	Aging	2/28/2019	5/8/2022
PAR-19-134	Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)	AD/ADRD Aging	12/21/2018	1/8/2022
PAR-19-133	Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	AD/ADRD Aging	12/21/2018	1/8/2022
PA-19-094	Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed)	AD/ADRD Aging	11/29/2018	1/8/2022
PA-19-095	Emotion Regulation, Aging and Mental Disorder (R21 Clinical Trial Not Allowed)	AD/ADRD Aging	11/29/2018	1/8/2022
PA-18-932	Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)	AD/ADRD Aging	9/21/2018	1/8/2022

Research & Funding FAQs

Access frequently asked questions related to NIA research and funding.